Graphical abstract from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells

Graphical abstract from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells

<p>Graphical abstract. A multi-omics analysis of the glioblastoma tumor microenvironment revealed that biglycan, predominantly expressed by inflammatory BTICs, drives tumor growth. The graphics were generated with Biorender.com.</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Reza Mirzaei (15306062) (author)
Diğer Yazarlar:	Charlotte D'Mello (15306065) (author), Marina Liu (15306068) (author), Ana Nikolic (15306071) (author), Mehul Kumar (15306074) (author), Frank Visser (15306077) (author), Pinaki Bose (15306080) (author), Marco Gallo (8808401) (author), V. Wee Yong (15306083) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Tumor Biology Molecular and Cellular Biology CNS Cancers Gliomas, Glioblastomas Stem Cell Biology Cancer stem cells Tumor Heterogeneity
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Supplementary Table S1 from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
Yazar:: Reza Mirzaei (15306062)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
Yazar:: Reza Mirzaei (15306062)
Baskı/Yayın Bilgisi: (2025)

Figure S1 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
Yazar:: Michael Kilian (16697663)
Baskı/Yayın Bilgisi: (2025)

Figure S2 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
Yazar:: Michael Kilian (16697663)
Baskı/Yayın Bilgisi: (2025)

Figure S3 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
Yazar:: Michael Kilian (16697663)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figures from Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets
Yazar:: Defne Bayik (14961098)
Baskı/Yayın Bilgisi: (2025)

Table S1 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Yazar:: Lanpeng Chen (16918293)
Baskı/Yayın Bilgisi: (2025)

Table S2 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Yazar:: Lanpeng Chen (16918293)
Baskı/Yayın Bilgisi: (2025)

Table S3 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Yazar:: Lanpeng Chen (16918293)
Baskı/Yayın Bilgisi: (2025)

Table S4 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Yazar:: Lanpeng Chen (16918293)
Baskı/Yayın Bilgisi: (2025)

Table S5 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Yazar:: Lanpeng Chen (16918293)
Baskı/Yayın Bilgisi: (2025)

Table S6 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Yazar:: Lanpeng Chen (16918293)
Baskı/Yayın Bilgisi: (2025)

Table S7 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Yazar:: Lanpeng Chen (16918293)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma
Yazar:: Isha Mondal (16721699)
Baskı/Yayın Bilgisi: (2025)

Supplementary video from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Yazar:: Min Wu (14962986)
Baskı/Yayın Bilgisi: (2025)

Table S1 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Yazar:: Min Wu (14962986)
Baskı/Yayın Bilgisi: (2025)

Table S2 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Yazar:: Min Wu (14962986)
Baskı/Yayın Bilgisi: (2025)

Table S3 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Yazar:: Min Wu (14962986)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 1_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.csv
Yazar:: Zhongyi Zhang (219440)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 2_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.pdf
Yazar:: Zhongyi Zhang (219440)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Yazar:: Francesca Orzan (15055579)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 2 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Yazar:: Francesca Orzan (15055579)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 3 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Yazar:: Francesca Orzan (15055579)
Baskı/Yayın Bilgisi: (2025)

Graphical abstract.
Yazar:: Ji-Xin Zhao (22056386)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S1 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
Yazar:: Sied Kebir (15048732)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S2 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
Yazar:: Sied Kebir (15048732)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S3 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
Yazar:: Sied Kebir (15048732)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S4 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
Yazar:: Sied Kebir (15048732)
Baskı/Yayın Bilgisi: (2025)

Supplementary Tables S1-4 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
Yazar:: Sied Kebir (15048732)
Baskı/Yayın Bilgisi: (2025)

Table S2 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Yazar:: Joseph Toker (15399882)
Baskı/Yayın Bilgisi: (2025)

Table S3 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Yazar:: Joseph Toker (15399882)
Baskı/Yayın Bilgisi: (2025)

Table S4 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Yazar:: Joseph Toker (15399882)
Baskı/Yayın Bilgisi: (2025)

Table S5 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Yazar:: Joseph Toker (15399882)
Baskı/Yayın Bilgisi: (2025)

Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Yazar:: Joseph Toker (15399882)
Baskı/Yayın Bilgisi: (2025)

Table S7 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Yazar:: Joseph Toker (15399882)
Baskı/Yayın Bilgisi: (2025)

Table S8 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Yazar:: Joseph Toker (15399882)
Baskı/Yayın Bilgisi: (2025)

Source Data from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors
Yazar:: Takeru Oka (15386810)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors
Yazar:: Takeru Oka (15386810)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Yazar:: Qingsheng Xu (17078830)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S3 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Yazar:: Qingsheng Xu (17078830)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_9gn55g5iorjgn0ohdgdsadp7et